The company confirmed it expects to have enough cash for 3 years Hopefully, this means no further dilution.
The question is: If enough cash for 3 years, what was the urgent need for this sale agreement?
Entry into a Material Definitive Agreement.
On July 16, 2020, Pluristem Therapeutics Inc., or the registrant, entered into an Open Market Sale AgreementSM, or the Sale Agreement, with Jefferies LLC, or Jefferies, as agent, pursuant to which the registrant may issue and sell shares of its common stock having an aggregate offering price of up to $75 million from time to time through Jefferies.